These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 966806)

  • 1. [Human Placental Lactogen (HPL) in the diagnosis of risk pregnancy].
    Stiglmayer R
    Jugosl Ginekol Opstet; 1976; 16(1):53-8. PubMed ID: 966806
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of the determination of free estriol (E3) and of placental lactogen (HPL) in the monitoring of high-risk pregnancy].
    Ghionni A; Briani G; Pasini L
    Minerva Ginecol; 1979; 31(1-2):13-8. PubMed ID: 471308
    [No Abstract]   [Full Text] [Related]  

  • 3. [The determination of human placental lactogen (HPL) for hormonal supervision in late pregnancy].
    Nieder J; Kapitza W
    Zentralbl Gynakol; 1976; 98(18):1129-36. PubMed ID: 983489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary oestriol and serum activities of human placental lactogen and heat stable alkaline phosphatase as indicators of fetoplacental function.
    Karjalainen O; Stenman U; Widholm O
    Ann Chir Gynaecol Fenn; 1975; 64(1):50-4. PubMed ID: 1155905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human placental lactogen: a predictor of perinatal outcome?
    Zlatnik FJ; Varner MW; Hauser KS
    Obstet Gynecol; 1979 Aug; 54(2):205-10. PubMed ID: 460755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Human placental lactogen (hPL)].
    Okamura M; Mizutani S; Itakura A
    Nihon Rinsho; 1999 Dec; 57 Suppl():299-301. PubMed ID: 10778122
    [No Abstract]   [Full Text] [Related]  

  • 7. [The monitoring of risk pregnancies by E3 and HPL].
    Bieglmayer C; Spona J
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():38-42. PubMed ID: 6211052
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical indications for targeted long-term monitoring of risk pregnancy using radioimmunologic HPL determination].
    Herter U; Alexander H; Radzuweit H
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():50-6. PubMed ID: 6211054
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of the HPL analysis kit in cases of abnormal pregnancy].
    Hashimoto T
    Horumon To Rinsho; 1974 Aug; 22(8):979-82. PubMed ID: 4476262
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical indications for the purposeful monitoring of at-risk pregnancies using radioimmunological HPL determinations].
    Herter U; Alexander H; Radzuweit H
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():50-6. PubMed ID: 6242694
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of plasmaestriol and HPL in high risk pregnancies].
    Duenhoelter JH; Whalley PJ
    Arch Gynecol; 1979 Jul; 228(1-4):229-30. PubMed ID: 485318
    [No Abstract]   [Full Text] [Related]  

  • 12. [Monitoring of at-risk pregnancies through E3 and HPL].
    Bieglmayer C; Spona J
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():38-42. PubMed ID: 6242692
    [No Abstract]   [Full Text] [Related]  

  • 13. [Monitoring of HPL, estriol and estetrol in high-risk pregnancy].
    Gherzi R; Pastore M; Labate D
    Minerva Ginecol; 1981 Oct; 33(10):911-6. PubMed ID: 7312213
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum levels of oestriol and human placental lactogen.
    Grudzinskas JG
    Med J Aust; 1980 Mar; 1(6):281. PubMed ID: 7374594
    [No Abstract]   [Full Text] [Related]  

  • 15. [Normal and risk pregnancy monitored by means of HPL (human placental lactogen)].
    Strozová A; Textoris R
    Bratisl Lek Listy; 1976; 66(4):466-73. PubMed ID: 1016862
    [No Abstract]   [Full Text] [Related]  

  • 16. The effectiveness of human placental lactogen measurements as an adjunct in decreasing perinatal deaths. Results of a retrospective and a randomized controlled prospective study.
    Spellacy WN; Buhi WC; Birk SA
    Am J Obstet Gynecol; 1975 Mar; 121(6):835-44. PubMed ID: 1091148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on blood level of human placental lactogen in abnormal pregnancy.
    Samanta B; Dutta GP
    J Indian Med Assoc; 1989 Sep; 87(9):205-7. PubMed ID: 2621369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human placentar lactogen (HPL) in the serum. Its diagnostic value in intra-uterine retardation of growth].
    Bellmann O; Lang N
    Z Geburtshilfe Perinatol; 1973 Apr; 177(2):97-109. PubMed ID: 4718770
    [No Abstract]   [Full Text] [Related]  

  • 19. [The laboratory in monitoring high-risk pregnancy].
    Radillo L; Cociancich G; D'Atri A; Ghionni A; Mangiarotti M
    Quad Sclavo Diagn; 1981 Jun; 17(2):164-71. PubMed ID: 6973774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human placental lactogen (HPL) in serum in complicated early pregnancy.
    Ylikorkala O; Jouppila P
    J Obstet Gynaecol Br Commonw; 1973 Dec; 80(12):1040-5. PubMed ID: 4761378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.